Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04931342
Title A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

fallopian tube cancer

peritoneum cancer

ovarian carcinosarcoma

ovary epithelial cancer

malignant ovarian Brenner tumor

ovarian mucinous adenocarcinoma

ovarian clear cell carcinoma

ovarian endometrial cancer

ovarian serous carcinoma

ovarian seromucinous carcinoma

small-cell carcinoma of the ovary of hypercalcemic type

Therapies

Cobimetinib

Ado-trastuzumab emtansine

Ipatasertib + Paclitaxel

Atezolizumab + Bevacizumab

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL


No variant requirements are available.